Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -4.72% is 129% below its 5-year average of -2.06%, around the middle of its 5-year range (-11.51%–6.71%).
As of the fiscal period ended Wednesday, December 31, 2025. 48.74% above its 12-month average of -9.21%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q4 FY2025 (2025-12-31): -4.72%.
RETURN ON INVESTED CAPITAL (ROIC)
-4.72%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-9.21%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-4.82%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-2.06%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-5.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
-10.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
+48.74%
CURRENT VS 3Y AVG
+2.06%
CURRENT VS 5Y AVG
-129.00%
CURRENT VS 10Y AVG
+13.76%
CURRENT VS 15Y AVG
+54.91%
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-34.44%
median of 682 covered companies
CURRENT VS SECTOR MEDIAN
+86.29%
vs the sector median at left
InterCure Ltd.
Market Cap
$65.15M
Return on Invested Capital (ROIC)
-4.72%
TTM Avg
-9.21%
3Y Avg
-4.82%
5Y Avg
-2.06%
Market Cap
$64.37M
Return on Invested Capital (ROIC)
-56.22%
TTM Avg
-67.31%
3Y Avg
-52.91%
5Y Avg
-45.67%
Market Cap
$66.00M
Return on Invested Capital (ROIC)
-83.74%
TTM Avg
-153.15%
3Y Avg
-164.21%
5Y Avg
-165.99%
Market Cap
$63.41M
Return on Invested Capital (ROIC)
-6.79%
TTM Avg
-4.87%
3Y Avg
-47.70%
5Y Avg
-62.00%
Market Cap
$64.06M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-165.22%
3Y Avg
-160.52%
5Y Avg
-107.11%
Market Cap
$66.29M
Return on Invested Capital (ROIC)
N/A
TTM Avg
-86.10%
3Y Avg
-83.22%
5Y Avg
-74.34%
Market Cap
$67.52M
Return on Invested Capital (ROIC)
-40.22%
TTM Avg
-72.23%
3Y Avg
-74.75%
5Y Avg
-58.95%
Market Cap
$62.54M
Return on Invested Capital (ROIC)
-52.40%
TTM Avg
-44.92%
3Y Avg
-44.92%
5Y Avg
-44.02%
Market Cap
$67.80M
Return on Invested Capital (ROIC)
-6.75%
TTM Avg
20.47%
3Y Avg
-36.30%
5Y Avg
-23.36%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| InterCure Ltd. (INCR) | $65.15M | -4.72% | -9.21% | -4.82% | -2.06% |
| Pliant Therapeutics, Inc. (PLRX)vs › | $64.37M | -56.22% | -67.31% | -52.91% | -45.67% |
| Cingulate Inc. (CING)vs › | $66.00M | -83.74% | -153.15% | -164.21% | -165.99% |
| Heron Therapeutics, Inc. (HRTX)vs › | $63.41M | -6.79% | -4.87% | -47.70% | -62.00% |
| Alps Group Inc (ALPS)vs › | $64.06M | N/A | -165.22% | -160.52% | -107.11% |
| Gossamer Bio, Inc. (GOSS)vs › | $66.29M | N/A | -86.10% | -83.22% | -74.34% |
| iBio, Inc. (IBIO)vs › | $67.52M | -40.22% | -72.23% | -74.75% | -58.95% |
| Kalaris Therapeutics Inc (KLRS)vs › | $62.54M | -52.40% | -44.92% | -44.92% | -44.02% |
| Champions Oncology, Inc. (CSBR)vs › | $67.80M | -6.75% | 20.47% | -36.30% | -23.36% |
| Fortress Biotech, Inc. (FBIO)vs › | $69.18M | -10.85% | -101.00% | -120.85% | -96.47% |
ROIC
-4.7%
ROE
-8.8%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2025-12-31 | -4.72% |
| 2025-09-30 | -8.07% |
| 2025-06-30 | -10.75% |
| 2025-03-31 | -11.51% |
| 2024-12-31 | -11.00% |
| 2024-09-30 | -9.21% |
| 2024-06-30 | -7.09% |
| 2024-03-31 | -6.83% |
| 2023-12-31 | -6.21% |
| 2023-09-30 | -2.80% |
| 2023-06-30 | 3.64% |
| 2023-03-31 | 5.18% |
| 2022-12-31 | 6.71% |
| 2022-09-30 | 5.96% |
| 2022-06-30 | 4.99% |
| 2022-03-31 | 3.84% |
| 2021-12-31 | 2.64% |
| 2021-09-30 | 4.17% |
| 2021-06-30 | 4.37% |
| 2021-03-31 | 4.83% |
| 2020-12-31 | -11.43% |
| 2020-09-30 | -19.22% |
| 2020-06-30 | -32.27% |
| 2020-03-31 | -37.46% |
| 2019-12-31 | -0.71% |
| 2019-09-30 | 12.19% |
| 2019-06-30 | 6.87% |
| 2019-03-31 | 44.78% |
| 2018-12-31 | -28.31% |
| 2018-09-30 | -20.77% |
| 2018-06-30 | -21.90% |
| 2018-03-31 | -20.50% |
| 2017-12-31 | -11.79% |
| 2017-09-30 | -5.96% |
| 2017-06-30 | 0.01% |
| 2017-03-31 | -1.35% |
| 2016-12-31 | 4.68% |
| 2016-09-30 | 1.39% |
| 2016-06-30 | -6.92% |
| 2016-03-31 | -4.79% |
| 2015-12-31 | -20.85% |
| 2015-09-30 | -16.51% |
| 2015-06-30 | -10.80% |
| 2015-03-31 | -17.22% |
| 2014-12-31 | -235.39% |
| 2014-09-30 | -60.84% |
| 2014-06-30 | -36.76% |
| 2014-03-31 | -33.73% |
| 2013-12-31 | -47.11% |
| 2013-09-30 | -59.70% |
| 2013-06-30 | -46.08% |
| 2013-03-31 | -31.77% |
| 2012-12-31 | -18.96% |
| 2012-09-30 | -13.56% |
| 2012-06-30 | -65.46% |
| 2012-03-31 | -60.16% |
